Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis
1 other identifier
interventional
140
1 country
1
Brief Summary
The goal of this study is to evaluate change in symptoms using semiconductor embedded gloves for hand osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2024
CompletedFirst Posted
Study publicly available on registry
December 20, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedOctober 21, 2025
October 1, 2025
12 months
November 5, 2024
October 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain as measured by the Visual Analog Scale (VAS)
The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. The minimum number is zero meaning no pain and maximum number is 10 meaning the most pain the patient has every felt in their entire life. Lower scores are ideal while higher scores are indicative of the patient in a lot of pain.
Baseline and weekly for 9 months
Secondary Outcomes (4)
Change in patient hand function as determined by the Australian Canadian Osteoarthritis Hand Index (AUSCAN)
Baseline, 3 months, 6 months, and 9 months
Change in patient hand function as determined by the Functional Index for Hand Osteoarthritis (FIHOA)
Baseline, 3 months, 6 months, and 9 months
Change in patient grip strength
Baseline, 3 months, 6 months, and 9 months
Radiographic changes as determined by hand x-rays.
Baseline and 9 months
Study Arms (2)
Semiconductor circulation gloves
ACTIVE COMPARATORThe gloves will have semiconductors embedded in the fabric.
Placebo circulation gloves
PLACEBO COMPARATORThe gloves will look identical to the active circulation gloves, but will not have semiconductors embedded into the fabric
Interventions
Non-invasive class I medical device, circulation gloves with semiconductors embedded in the fabric.
These gloves will look and feel identical to the active circulation gloves, but will not have semiconductors embedded in the fabric.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
- Patients age 40-75
- Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
- Patients who are willing and able to sign corresponding research subject consent form.
You may not qualify if:
- Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
- Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
- Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
- Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
- Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
- Patient has a history of peripheral neuropathy
- Patient has chronic pain conditions unrelated to hand condition
- Patient has auto-immune or auto-inflammatory diseases
- Patient has used tobacco within the last 90 days
- Patient is not within the ages of 40-75
- Patient has an active infection (local or systemic)
- Patient is unwilling or unable to sign the corresponding research subject consent form
- Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Altoona Center for Clinical Researchlead
- INCREDIWEAR HOLDINGS, INC.collaborator
Study Sites (1)
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635, United States
Related Publications (1)
Marino K, Lee R, Lee P. Effect of Germanium-Embedded Knee Sleeve on Osteoarthritis of the Knee. Orthop J Sports Med. 2019 Oct 25;7(10):2325967119879124. doi: 10.1177/2325967119879124. eCollection 2019 Oct.
PMID: 31696136RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2024
First Posted
December 20, 2024
Study Start
January 1, 2025
Primary Completion
December 31, 2025
Study Completion
January 1, 2026
Last Updated
October 21, 2025
Record last verified: 2025-10